Publikace
- Farmakoterapie osteoporózy: vápník vitamin D hormonální léčba selektivní modulátory receptorů pro estrogeny a stroncium ranelát.2009 | 1. lékařská fakulta
- Interindividual differences contribute to variation in microbiota composition more than hormonal status: A prospective study2023 | 1. lékařská fakulta
- A decrease in serum 1,25(OH)(2)D after elective hip replacement and during bone healing is associated with changes in serum iron and plasma FGF232022 | 1. lékařská fakulta, 3. lékařská fakulta
- Menopausal Transition: Prospective Study of Estrogen Status, Circulating MicroRNAs, and Biomarkers of Bone Metabolism2022 | 1. lékařská fakulta
- Treatment of postmenopausal osteoporosis patients with teriparatide for 24 months reverts forming bone quality indices to premenopausal healthy control values2022 | 1. lékařská fakulta
- Decrease in serum calcitriol (but not free 25-hydroxyvitamin D) concentration in hip fracture healing2021 | 1. lékařská fakulta, 3. lékařská fakulta
- Efficacy of teriparatide compared with risedronate on FRAX(R)-defined major osteoporotic fractures: results of the VERO clinical trial2020 | 1. lékařská fakulta
- S100A4 is elevated in axial spondyloarthritis: a potential link to disease severity2020 | 1. lékařská fakulta
- Serum 25-hydroxy-vitamin D and the risk of fractures in the teriparatide versus risedronate VERO clinical trial2019 | 1. lékařská fakulta
- Glukokortikoidy, skelet a revmatické choroby2019 | 1. lékařská fakulta
Loading network view...